Related Experiment Video
Updated: Jan 29, 2026

Isolation of Human Endothelial Cells from Normal Colon and Colorectal Carcinoma - An Improved Protocol
Published on: April 4, 2018
Colorectal Carcinoma and Emerging Targeted Therapies
Nabin Khanal1, Smrity Upadhyay1, Peter T Silberstein1
1and are third year internal medicine residents, both in the Department of Internal Medicine, and is the division chief of hematology/oncology and professor of internal medicine, all at Creighton University in Omaha, Nebraska. Dr. Silberstein is also the chief of oncology at the VA Nebraska-Western Iowa Health Care System in Omaha, Nebraska.
Abstract:
Targeted therapies for specific mutations in colorectal cancer have led to an increase in patient overall survival.
More Related Videos
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
09:28Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Emerging Adulthood
Introduction Cardiac Emergencies
Gene Therapy
Applications of GIS: Disaster Management and Emergency Response
Group Therapy